Trump Outs Top White House Aide as Being on ‘Fat Drugs’
The comment came as Trump announced plans to slim down the cost of “fat drugs.”
Donald Trump has outed White House communications chief and resident attack dog Steven Cheung as a user of “fat drugs.”
Announcing plans to slim down the cost of popular weight loss drugs, the president began naming his Cabinet members and aides, asking if they needed such medication.

US President Donald Trump alongside White House Communications Director Steven Cheung.
ROBERTO SCHMIDT/AFP via Getty Images
“You taking any of this stuff, Howard?” he asked Commerce Secretary Howard Lutnick.
“Not yet,” Lutnick replied.
“CMS administrator Mehmet Oz, he doesn’t take it,” Trump said.
Get the best of The Beast delivered right to your inbox
By clicking “SUBSCRIBE” you agree to our Terms of Use and Privacy Policy.
“Where’s Steve?” the president then asked. “Head of public relations for the White House. He’s taking it.”

White House Communications Director Steven Cheung looks on as U.S. President Donald Trump walks off Air Force One.
Anna Moneymaker/Getty Images
Steven Cheung is a former spokesperson for the UFC, who joined Trump’s 2016 campaign and served as his director of strategic response.
He is now the White House communications director, working alongside Press Secretary Karoline Leavitt, and is known for his combative style and profanity-laced responses to media inquiries.
“You must be truly f--king stupid if you think we’re not transparent,” he said recently, when asked by Huffington Post reporter S.V Date why many of the president’s remarks were not posted as transcripts.
Asked if he cared to comment on Thursday, Cheung told the Daily Beast: “It’s important to encourage others to explore options to address health concerns by speaking openly and honestly about it.”
Trump’s unexpected outing of his 43-year-old aide’s weight loss attempts came as he announced a deal on Thursday that could significantly expand access to hugely popular obesity drugs by reducing the price to as little as $150 a month.
Trump has long fixated on GLP-1 medications, often expressing frustration about the high cost of what he has dubbed the “fat drug” in the U.S.
But the president’s own health has also been in the spotlight lately, from his recent chronic venous insufficiency diagnoses (which has caused his swollen ankles) and frequent hand bruising, to his revelation that he recently had an MRI scan.
In terms of his own weight, an official medical report released by the White House after his first medical examination in April recorded him at 224 pounds, although some observers have questioned this.
Trump’s most recent check up took place last month, but the latest report from White House doctor Sean Barbabella did not record his weight.
In the Oval Office on Thursday, Trump announced concessions from Eli Lilly and Novo Nordisk that will lower the price of the companies’ weight-loss drugs for some patients who are covered by Medicare and Medicaid.
“It’s a triumph for American patients that will save lives and improve the health of millions and millions of Americans,” he said, flanked by pharmaceutical executives and Cabinet members.
Trump on Weight Loss Drugs: Howard Lutnick—You taking any of this stuff Howard?
— Acyn (@Acyn) November 6, 2025
Lutnick: Not yet
Trump: Mehmet Oz, he doesn’t take it. Where’s Steve… Head of public relations for the White House. He’s taking it. pic.twitter.com/Yboa5A09is
Under the administration’s plan, drug makers Eli Lilly and Novo Nordisk would sell their medications to Medicare for $149 per month for the lowest dose and $245 per month for larger doses.
The drugs would also be will be offered at discounted rates through through a new administration website TrumpRx.gov, which is expected to go live next year.
Consumers would then be able to purchase the drugs directly in cash for an average of $350 or less per month - less than the current rate of about $500 per month.
Unlock a year of full access to The Looker and The Daily Beast for $35.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.
Register below to read this article for free or subscribe
to unlock unlimited access to The Looker and The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.
Sign in
Login dialog



ADVERTISEMENT
Sign in or create an account
Login dialog
Loading comments…
ADVERTISEMENT